Loading clinical trials...
Loading clinical trials...
Risk Assessment of Carotid Plaques Based on Pressure Estimation Using 3D Contrast-enhanced Ultrasound
This is an open-label, non-randomized study conducted at Thomas Jefferson University comparing pressure-gradient estimates (obtained between a carotid plaque and the carotid artery) to imaging and histology markers of plaque vulnerability. There is an inverse relationship between the subharmonic signal magnitude from contrast-enhanced ultrasound microbubbles and ambient pressure. This pressure estimation technique (referred as SHAPE) will be used to estimate the pressure gradient across the carotid plaque cap noninvasively in vivo.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Thomas jefferson University
Philadelphia, Pennsylvania, United States
Start Date
December 1, 2020
Primary Completion Date
April 5, 2023
Completion Date
December 31, 2025
Last Updated
April 24, 2025
20
ACTUAL participants
Perflutren
DIAGNOSTIC_TEST
Lead Sponsor
Thomas Jefferson University
NCT06214429
NCT06541691
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06253962